Leonhard X Heinz

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Annals of the rheumatic diseases

Science signaling

Nature communications

Nature

Medical University of Vienna

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Vienna Jun 02 2020

Austria

Group Leader :: Department of Internal Medicine III, Division of Rheumatology

CeMM Research Center for Molecular Medicine Oct 01 2011 - Apr 30 2020

Austria

Postdoctoral Fellow :: Superti-Furga Lab

Publications

Jared R Coombs, Alina Zamoshnikova, Caroline L Holley, Stephen T Bradford, Daniel Eng Thiam Teo, Camille Chauvin, Lionel F Poulin, Nazarii Vitak, Connie M Ross, Manasa Mellacheruvu, Rebecca C Coll, Leonhard X Heinz, Sabrina Sofia Burgener, Stefan Emming, Mathias Chamaillard, Dave Boucher, Kate Schroder
NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome. Science signaling 17 (820) (2024)
Jared R Coombs, Alina Zamoshnikova, Caroline L Holley, Stephen T Bradford, Daniel Eng Thiam Teo, Camille Chauvin, Lionel F Poulin, Nazarii Vitak, Connie M Ross, Manasa Mellacheruvu, Rebecca C Coll, Leonhard X Heinz, Sabrina Sofia Burgener, Stefan Emming, Mathias Chamaillard, Dave Boucher, Kate Schroder
NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome. Science signaling 17 (820) (2024)
Jared R Coombs, Alina Zamoshnikova, Caroline L Holley, Stephen T Bradford, Daniel Eng Thiam Teo, Camille Chauvin, Lionel F Poulin, Nazarii Vitak, Connie M Ross, Manasa Mellacheruvu, Rebecca C Coll, Leonhard X Heinz, Sabrina Sofia Burgener, Stefan Emming, Mathias Chamaillard, Dave Boucher, Kate Schroder
NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome. Science signaling 17 (820) (2024)
Maximilian Kugler, Mirjam Dellinger, Felix Kartnig, Lena Müller, Teresa Preglej, Leonhard X Heinz, Elisabeth Simader, Lisa Göschl, Stephan E Puchner, Sebastian Weiss, Lisa E Shaw, Matthias Farlik, Wolfgang Weninger, Giulio Superti-Furga, Josef S Smolen, Guenter Steiner, Daniel Aletaha, Hans P Kiener, Myles J Lewis, Costantino Pitzalis, Anela Tosevska, Thomas Karonitsch, Michael Markus Bonelli
Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis. Annals of the rheumatic diseases (2023)
Michael Markus Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, Kamran Ghoreschi, Massimo Gadina, Leonhard X Heinz, Josef S Smolen, Daniel Aletaha, John O'Shea, Arian Laurence
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story. Annals of the rheumatic diseases (2023)
Andras Boeszoermenyi, Léa Bernaleau, Xudong Chen, Felix Kartnig, Min Xie, Haobo Zhang, Sensen Zhang, Maeva Delacrétaz, Anna Koren, Ann-Katrin Hopp, Vojtech Dvorak, Stefan Kubicek, Daniel Aletaha, Maojun Yang, Manuele Rebsamen, Leonhard X Heinz, Giulio Superti-Furga
A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity. Nature communications 14 (1) (2023)
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, Peter Mandl, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Maximilian Koblischke, Philipp Hofer, Lisa Göschl, Felix Kartnig, Thomas Deimel, Andreas Kerschbaumer, Thomas Hummel, Barbara Kornek, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Michael Markus Bonelli
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study. Annals of the rheumatic diseases 81 (12) (2022)
Michael Markus Bonelli, Daniel Mrak, Selma Tobudic, Daniela Sieghart, Maximilian Koblischke, Peter Mandl, Barbara Kornek, Elisabeth Simader, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Philipp Hofer, Kurt Redlich, Emma Husar-Memmer, Ruth Fritsch-Stork, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H Aberle, Markus Zeitlinger, Leonhard X Heinz, Daniel Aletaha
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial. Annals of the rheumatic diseases 81 (5) (2022)
Felix Kartnig, Daniel Mrak, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Göschl, Nikolaus Hommer, Margareta Mayer, Philipp Hofer, Thomas Hummel, Thomas Deimel, Irina Geßl, Antonia Puchner, Andreas Kerschbaumer, Renate Thalhammer, Alessandra Handisurya, Renate Kain, Stefan Winkler, Josef S Smolen, Karin Stiasny, Thomas Perkmann, Helmuth Haslacher, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Daniela Sieghart, Michael Markus Bonelli
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls. Annals of the rheumatic diseases (2022)
Daniel Mrak, Daniela Sieghart, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Göschl, Maximilian Koblischke, Nikolaus Hommer, Angelika Wagner, Margareta Mayer, Lorenz Schubert, Lukas Hartl, Karin Kozbial, Philipp Hofer, Felix Kartnig, Thomas Hummel, Andreas Kerschbaumer, Thomas Deimel, Antonia Puchner, Venugopal Gudipati, Renate Thalhammer, Petra Munda, Keziban Uyanik-Ünal, Andreas Zuckermann, Gottfried Novacek, Thomas Reiberger, Erika Garner-Spitzer, Roman Reindl-Schwaighofer, Renate Kain, Stefan Winkler, Josef S Smolen, Karin Stiasny, Gottfried F Fischer, Thomas Perkmann, Helmuth Haslacher, Markus Zeitlinger, Ursula Wiedermann, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Michael Markus Bonelli
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial. Nature communications 13 (1) (2022)
Daniel Mrak, Selma Tobudic, Maximilian Koblischke, Marianne Graninger, Helga Radner, Daniela Sieghart, Philipp Hofer, Thomas Perkmann, Helmuth Haslacher, Renate Thalhammer, Stefan Winkler, Stephan Blüml, Karin Stiasny, Judith H Aberle, Josef S Smolen, Leonhard X Heinz, Daniel Aletaha, Michael Markus Bonelli
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity. Annals of the rheumatic diseases 80 (10) (2021)
Leonhard X Heinz, JangEun Lee, Utkarsh Kapoor, Felix Kartnig, Vitaly Sedlyarov, Konstantinos Papakostas, Adrian César-Razquin, Patrick Essletzbichler, Ulrich Goldmann, Adrijana Stefanovic, Johannes W Bigenzahn, Stefania Scorzoni, Mattia D Pizzagalli, Ariel Bensimon, André C Müller, F James King, Jun Li, Enrico Girardi, M Lamine Mbow, Charles E Whitehurst, Manuele Rebsamen, Giulio Superti-Furga
TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature 581 (7808) (2020)
Johannes W Bigenzahn, Giovanna M Collu, Felix Kartnig, Melanie Pieraks, Gregory I Vladimer, Leonhard X Heinz, Vitaly Sedlyarov, Fiorella Schischlik, Astrid Fauster, Manuele Rebsamen, Katja Parapatics, Vincent A Blomen, André C Müller, Georg E Winter, Robert Kralovics, Thijn R Brummelkamp, Marek Mlodzik, Giulio Superti-Furga
LZTR1 is a regulator of RAS ubiquitination and signaling. Science (New York, N.Y.) 362 (6419) (2018)

Leonhard X Heinz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Leonhard X Heinz